| 3-methyladenine | (3-MA) |
| Antibody–drug conjugates | (ADCs) |
| Autophagy-related protein 9B | (ATG9B) |
| Bacillus Calmette–Guérin | (BCG) |
| Bladder cancer | (BC) |
| Chloroquine | (CQ) |
| Death-associated protein kinase 2 | (DAPK2) |
| Dolastatin 10 | (D10) |
| FAS-associated death domain | (FADD) |
| Fibroblast growth factor receptor | (FGFR) |
| Immune checkpoint inhibitor | (ICI) |
| Kyoto Encyclopedia of Genes and Genomes | (KEGG) |
| Muscle-invasive bladder cancer | (MIBC) |
| Knockout | (KO) |
| Monomethyl auristatin E | (MMAE) |
| Next-Generation Sequencing | (NGS) |
| Non-muscle-invasive bladder cancer | (NMIBC) |
| Poly-(ADP-ribose) polymerase | (PARP) |
| Receptor tyrosine kinases | (RTKs) |